NASDAQ:BCYC - Nasdaq - US0887861088 - ADR - Currency: USD
Taking everything into account, BCYC scores 3 out of 10 in our fundamental rating. BCYC was compared to 560 industry peers in the Biotechnology industry. The financial health of BCYC is average, but there are quite some concerns on its profitability. BCYC is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -22.99% | ||
ROE | -27.45% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | 1.35 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 14.86 | ||
Quick Ratio | 14.86 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
8.03
-0.02 (-0.25%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 21.62 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.75 | ||
P/tB | 0.75 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -22.99% | ||
ROE | -27.45% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 25.55% | ||
Cap/Sales | 7.1% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 14.86 | ||
Quick Ratio | 14.86 | ||
Altman-Z | 1.35 |